Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

ConditionsGastrostomy Gastric GastroEsophageal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorM.D. Anderson Cancer Center

About this trial

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Eligibility criteria

Qualifiers

Able to speak and read English, Spanish, Japanese or Korean

Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention

Age ≥ 18

Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract

Disqualifiers

None

Trial design

Treatments tested in this trial

Standard of Care
Control Group

Treatment groups

20 Participants

are divided into 2 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov